Bionano GenomicsBNGO
13F holders, Q2 2025 (June 30)1holders −47
1new positions
0sold out
$3.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Bionano Genomics Inc. (BNGO) in their 13F filings, down 47 from Q4 2024. 1 opened new positions and 0 sold out. The largest holder was Ancora Advisors LLC ($3).
- Company
- Bionano Genomics Inc.
- CUSIP
- 09075F305
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q2 2025: 1 shares bought, net +1 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ancora Advisors LLC | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is BNGO's weight in each manager's 13F, not the share of Bionano Genomics Inc. the manager owns.